Intra-individual variability of cardiac uptake on serial whole-body 18F-FDG PET

Amir H. Khandani, Carmen R. Isasi, M. Donald Blaufox

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objective: To measure the variability of cardiac uptake on serial whole-body 18F-FDG PET scans. Methods: Two hundred and eighteen whole-body PET scans were performed in 47 patients with different primary malignancies between October 1996 and April 2003 on a dedicated PET system. The number of scans per patient ranged between four and nine. Two experienced nuclear medicine physicians reviewed the scans retrospectively using the non-attenuation corrected images to assess the cardiac FDG uptake. Patients with cardiac uptake less or equal to lung uptake were assigned in the 'low' uptake group, and those with cardiac uptake more than the lung uptake were assigned to the 'high' uptake group. The reproducibility of cardiac uptake on serial whole-body PET scans and the effect of age, sex, weight, diabetes and primary diagnosis on cardiac uptake was evaluated. Results: There was very good reproducibility (intra-class correlation coefficient=0.77) of individual cardiac FDG uptake on serial whole-body PET scans. Diabetics (n=6) in comparison to non-diabetics were less likely to have high cardiac uptake (odds ratio (OR)=0.24, P<0.05). Patients with lymphoma (n=12) in comparison to patients with other primary diagnoses were more likely to have high cardiac uptake (OR=8.6, P<0.05). There was no association between cardiac uptake and age, sex or weight. Conclusion: Cardiac FDG uptake on whole-body PET does not appear to change significantly over time. It is likely that uptake is determined by individual characteristics; these likely include diabetes and primary diagnosis of lymphoma.

Original languageEnglish (US)
Pages (from-to)787-791
Number of pages5
JournalNuclear Medicine Communications
Volume26
Issue number9
DOIs
StatePublished - Sep 2005

Fingerprint

Fluorodeoxyglucose F18
Whole Body Imaging
Positron-Emission Tomography
Lymphoma
Odds Ratio
Weights and Measures
Lung
Nuclear Medicine
Physicians
Neoplasms

Keywords

  • F-FDG
  • Cardiac uptake
  • Whole-body PET

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Intra-individual variability of cardiac uptake on serial whole-body 18F-FDG PET. / Khandani, Amir H.; Isasi, Carmen R.; Blaufox, M. Donald.

In: Nuclear Medicine Communications, Vol. 26, No. 9, 09.2005, p. 787-791.

Research output: Contribution to journalArticle

@article{7ce63539bbc74b8c83f5f96ab1a82a0d,
title = "Intra-individual variability of cardiac uptake on serial whole-body 18F-FDG PET",
abstract = "Objective: To measure the variability of cardiac uptake on serial whole-body 18F-FDG PET scans. Methods: Two hundred and eighteen whole-body PET scans were performed in 47 patients with different primary malignancies between October 1996 and April 2003 on a dedicated PET system. The number of scans per patient ranged between four and nine. Two experienced nuclear medicine physicians reviewed the scans retrospectively using the non-attenuation corrected images to assess the cardiac FDG uptake. Patients with cardiac uptake less or equal to lung uptake were assigned in the 'low' uptake group, and those with cardiac uptake more than the lung uptake were assigned to the 'high' uptake group. The reproducibility of cardiac uptake on serial whole-body PET scans and the effect of age, sex, weight, diabetes and primary diagnosis on cardiac uptake was evaluated. Results: There was very good reproducibility (intra-class correlation coefficient=0.77) of individual cardiac FDG uptake on serial whole-body PET scans. Diabetics (n=6) in comparison to non-diabetics were less likely to have high cardiac uptake (odds ratio (OR)=0.24, P<0.05). Patients with lymphoma (n=12) in comparison to patients with other primary diagnoses were more likely to have high cardiac uptake (OR=8.6, P<0.05). There was no association between cardiac uptake and age, sex or weight. Conclusion: Cardiac FDG uptake on whole-body PET does not appear to change significantly over time. It is likely that uptake is determined by individual characteristics; these likely include diabetes and primary diagnosis of lymphoma.",
keywords = "F-FDG, Cardiac uptake, Whole-body PET",
author = "Khandani, {Amir H.} and Isasi, {Carmen R.} and Blaufox, {M. Donald}",
year = "2005",
month = "9",
doi = "10.1097/01.mnm.0000175264.33368.da",
language = "English (US)",
volume = "26",
pages = "787--791",
journal = "Nuclear Medicine Communications",
issn = "0143-3636",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Intra-individual variability of cardiac uptake on serial whole-body 18F-FDG PET

AU - Khandani, Amir H.

AU - Isasi, Carmen R.

AU - Blaufox, M. Donald

PY - 2005/9

Y1 - 2005/9

N2 - Objective: To measure the variability of cardiac uptake on serial whole-body 18F-FDG PET scans. Methods: Two hundred and eighteen whole-body PET scans were performed in 47 patients with different primary malignancies between October 1996 and April 2003 on a dedicated PET system. The number of scans per patient ranged between four and nine. Two experienced nuclear medicine physicians reviewed the scans retrospectively using the non-attenuation corrected images to assess the cardiac FDG uptake. Patients with cardiac uptake less or equal to lung uptake were assigned in the 'low' uptake group, and those with cardiac uptake more than the lung uptake were assigned to the 'high' uptake group. The reproducibility of cardiac uptake on serial whole-body PET scans and the effect of age, sex, weight, diabetes and primary diagnosis on cardiac uptake was evaluated. Results: There was very good reproducibility (intra-class correlation coefficient=0.77) of individual cardiac FDG uptake on serial whole-body PET scans. Diabetics (n=6) in comparison to non-diabetics were less likely to have high cardiac uptake (odds ratio (OR)=0.24, P<0.05). Patients with lymphoma (n=12) in comparison to patients with other primary diagnoses were more likely to have high cardiac uptake (OR=8.6, P<0.05). There was no association between cardiac uptake and age, sex or weight. Conclusion: Cardiac FDG uptake on whole-body PET does not appear to change significantly over time. It is likely that uptake is determined by individual characteristics; these likely include diabetes and primary diagnosis of lymphoma.

AB - Objective: To measure the variability of cardiac uptake on serial whole-body 18F-FDG PET scans. Methods: Two hundred and eighteen whole-body PET scans were performed in 47 patients with different primary malignancies between October 1996 and April 2003 on a dedicated PET system. The number of scans per patient ranged between four and nine. Two experienced nuclear medicine physicians reviewed the scans retrospectively using the non-attenuation corrected images to assess the cardiac FDG uptake. Patients with cardiac uptake less or equal to lung uptake were assigned in the 'low' uptake group, and those with cardiac uptake more than the lung uptake were assigned to the 'high' uptake group. The reproducibility of cardiac uptake on serial whole-body PET scans and the effect of age, sex, weight, diabetes and primary diagnosis on cardiac uptake was evaluated. Results: There was very good reproducibility (intra-class correlation coefficient=0.77) of individual cardiac FDG uptake on serial whole-body PET scans. Diabetics (n=6) in comparison to non-diabetics were less likely to have high cardiac uptake (odds ratio (OR)=0.24, P<0.05). Patients with lymphoma (n=12) in comparison to patients with other primary diagnoses were more likely to have high cardiac uptake (OR=8.6, P<0.05). There was no association between cardiac uptake and age, sex or weight. Conclusion: Cardiac FDG uptake on whole-body PET does not appear to change significantly over time. It is likely that uptake is determined by individual characteristics; these likely include diabetes and primary diagnosis of lymphoma.

KW - F-FDG

KW - Cardiac uptake

KW - Whole-body PET

UR - http://www.scopus.com/inward/record.url?scp=24044484403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24044484403&partnerID=8YFLogxK

U2 - 10.1097/01.mnm.0000175264.33368.da

DO - 10.1097/01.mnm.0000175264.33368.da

M3 - Article

C2 - 16096582

AN - SCOPUS:24044484403

VL - 26

SP - 787

EP - 791

JO - Nuclear Medicine Communications

JF - Nuclear Medicine Communications

SN - 0143-3636

IS - 9

ER -